JPX · 3902.T
Medical Data Vision Co., Ltd.
¥1,684¥0 (0.0%)
Medical Data Vision Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.53% below the high.
Loading market information…
JPX · 7743.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
SEED Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SEED Co.,Ltd.’s forward annual dividend is ¥15 per share, paid annual. The forward yield is 1.91% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
SEED Co.,Ltd.’s next earnings report is currently expected on Nov 9, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SEED Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision enhancement items, serving customers in Japan and across global markets. Their diverse contact lens collection features numerous daily disposable options, such as the SEED 1dayPure moisture, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV. They also offer specialized daily lenses, including multistage and astigmatism-correcting versions like the SEED 1dayPure moisture for astigmatism. Furthermore, SEED provides two-week disposable lenses through its SEED 2weekPure moisture series, which encompasses standard, multistage bifocal, and astigmatism-specific variants. Monthly replacement lenses, such as SEED MonthlyFine UV and monthly color lens UV, are also part of their portfolio, alongside advanced rigid gas permeable and medical contact lenses. In addition to vision correction products, SEED Co.,Ltd. designs and sells eyewear frames under well-known brands like Vivid Moon, ViVi fleurs, and Plusmix. The company also develops pharmaceutical products, including Adeno Test AD for the detection of adenovirus antigens, and other solutions aimed at improving visual health. Established in 1957, SEED Co.,Ltd. is based in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2024 | Nov 11, 2024 | ¥6 | ¥8.55B-0.37% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,684¥0 (0.0%)
Medical Data Vision Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.53% below the high.
¥1,633¥0 (0.0%)
CE Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.16% below the high.
¥2,107-¥3 (-0.14%)
Fuso Pharmaceutical Industries,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.72% below the high.
¥737+¥6 (+0.82%)
Medius Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.
¥4,975-¥10 (-0.2%)
Hoshi Iryo-Sanki Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.08% below the high.
¥749-¥17 (-2.22%)
CanBas Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 24.42% below the high.
¥1,150-¥2 (-0.17%)
Wellness Communications Corporation’s quoted price sits in the lower half of its reported 52-week range, 24.34% below the high.
¥972-¥3 (-0.31%)
Ohki Healthcare Holdings Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.97% below the high.
